Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michele P, McCullough"'
Autor:
Daniel J. Gromer, Brian D. Plikaytis, Michele P. McCullough, Sonia Tandon Wimalasena, Nadine Rouphael
Publikováno v:
Vaccines, Vol 12, Iss 7, p 809 (2024)
Vaccine immunogenicity and reactogenicity depend on recipient and vaccine characteristics. We hypothesized that healthy adults reporting higher reactogenicity from seasonal inactivated influenza vaccine (IIV) developed higher antibody titers compared
Externí odkaz:
https://doaj.org/article/024b2066bf09460aa3486e9c933dd8ad
Autor:
Nadine G. Rouphael, Lilin Lai, Sonia Tandon, Michele Paine McCullough, Yunchuan Kong, Sarah Kabbani, Muktha S. Natrajan, Yongxian Xu, Yerun Zhu, Dongli Wang, Jesse O’Shea, Amy Sherman, Tianwei Yu, Sebastien Henry, Devin McAllister, Daniel Stadlbauer, Surender Khurana, Hana Golding, Florian Krammer, Mark J. Mulligan, Mark R. Prausnitz
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-9 (2021)
Abstract In a phase 1 randomized, single-center clinical trial, inactivated influenza virus vaccine delivered through dissolvable microneedle patches (MNPs) was found to be safe and immunogenic. Here, we compare the humoral and cellular immunologic r
Externí odkaz:
https://doaj.org/article/5b49040c2002496f8128ac3623836663
Autor:
Lisa A, Jackson, Evan J, Anderson, Nadine G, Rouphael, Paul C, Roberts, Mamodikoe, Makhene, Rhea N, Coler, Michele P, McCullough, James D, Chappell, Mark R, Denison, Laura J, Stevens, Andrea J, Pruijssers, Adrian, McDermott, Britta, Flach, Nicole A, Doria-Rose, Kizzmekia S, Corbett, Kaitlyn M, Morabito, Sijy, O'Dell, Stephen D, Schmidt, Phillip A, Swanson, Marcelino, Padilla, John R, Mascola, Kathleen M, Neuzil, Hamilton, Bennett, Wellington, Sun, Etza, Peters, Mat, Makowski, Jim, Albert, Kaitlyn, Cross, Wendy, Buchanan, Rhonda, Pikaart-Tautges, Julie E, Ledgerwood, Barney S, Graham, John H, Beigel, Gordon, Bernard
Publikováno v:
The New England Journal of Medicine
New England Journal of Medicine
New England Journal of Medicine
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized pre